Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px
Document › Details

Thermo Fisher Scientific Inc.. (6/4/18). "Press Release: Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center". Boston, MA & San Diego, CA.

Region Region Cambridge, MA
  Country United States (USA)
Organisations Organisation Thermo Fisher Precision Medicine Science Center (PMSC) (Cambridge, MA, US)
  Group Thermo Fisher (Group)
  Organisation 2 Cedars-Sinai Medical Center
Products Product personalised medicine / precision medicine
  Product 2 proteomics
Index term Index term Thermo Fisher–Cedars-Sinai Medical Center: personalised medicine, 201806– collab precision medicine using proteomics Thermo PMSC with J van Eyk
Persons Person Chen, Emily (Thermo Fisher 201806 Senior Director Thermo Fisher Precision Medicine Science Center)
  Person 2 Van Eyk, Jennifer (Jenny) (Cedars-Sinai Medical Center 201406 before Johns Hopkins Univ 201306 Senior Researcher)
     


Supports development of analytical workflows to generate precise molecular profiles of patients


BIO 2018 and ASMS 2018 -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today officially opened its U.S. Precision Medicine Science Center (PMSC) in Cambridge, Mass. The Center offers access to advanced "omics" technologies and expertise to help collaborators develop analytical workflows that generate precise molecular profiles of patients. This information will ultimately be used in clinical settings to more effectively treat disease.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/83430241-thermo-fisher-us-precision-medicine-science-center/

In addition to providing access to the industry's most advanced analytical technologies, the PMSC's team of in-house scientists helps partners develop standard protocols that enable them to compress R&D timelines and quickly progress from biomarker discovery to assay development. The team includes Thermo Fisher experts in biochemistry, mass spectrometry, molecular biology and data science.

"For health and science innovators, a bottleneck exists today between the discovery of biomarkers and their widespread use at the point of care," said Emily Chen, senior director, Thermo Fisher Precision Medicine Science Center. "Our goal at the PMSC is to remove that bottleneck and help scientists and physicians reduce the time it takes to demonstrate clinic validity and utility."

"Precision medicine needs to be based on high-quality data, and proteomics is central to that," said PMSC collaborator Jennifer Van Eyk, PhD, Cedars-Sinai Medical Center in Los Angeles. "Our work with the team at the PMSC is helping us accelerate the important journey from discovery to patient care."

The PMSC offers access to advanced technologies spanning genomic, proteomic and metabolomic analysis. From analyzing genomic data with next-generation sequencers to identifying proteins and metabolites using advanced mass spectrometry, collaborators can rapidly move from research to clinical workflow development. With support from the PMSC, scientists can:

> Put complex analytical technologies at the center of simplified workflows

> Generate reproducible research with an emphasis on scalability and, ultimately, clinical utility

> Enable processes that produce the highest quality data, consistently

> Change the culture of method sharing so a larger community can benefit

> Overcome lack of technical expertise as a barrier to discovery by quickly accessing the best tools and skillsets needed.

In 2017, Thermo Fisher opened its Precision Medicine Science Center in Guangzhou, China. Like the PMSC, the Guangzhou Center serves as a hub for partners seeking to establish standardized precision medicine platforms as well as for joint research and development.

To learn more about the U.S. Precision Medicine Science Center, click here or visit www.thermofisher.com/precisionmedicine.


About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.


Media Contact Information:

Charlotte McCormack
Phone: 781-622-1202
E-mail: charlotte.mccormack@thermofisher.com

Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: ken.apicerno@thermofisher.com

   
Record changed: 2018-07-04

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for Thermo Fisher (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x60px




» top